West Pharmaceutical Services logo

West Pharmaceutical ServicesNYSE: WST

Profile

Sector:

Healthcare

Country:

United States

IPO:

17 March 1980

Next earnings report:

26 July 2024

Last dividends:

23 April 2024

Next dividends:

31 July 2024
$23.43 B
-32%vs. 3y high
96%vs. sector
-38%vs. 3y high
71%vs. sector
-48%vs. 3y high
93%vs. sector
-41%vs. 3y high
72%vs. sector

Price

after hours | Wed, 03 Jul 2024 19:19:19 GMT
$321.66-$0.94(-0.29%)
$695.40 M$728.66 M
$695.40 M$115.30 M

Analysts recommendations

Institutional Ownership

WST Latest News

Reasons to Hold West Pharmaceutical (WST) in Your Portfolio Now
zacks.com21 June 2024 Sentiment: -

West Pharmaceutical (WST) continues to gain momentum due to its strength in the Proprietary Products business. However, forex concerns persist.

West Introduces Daikyo Crystal Zenith® (CZ) Ready-to-Use Nested Vials in Tub at the International Society for Cell and Gene Therapy
prnewswire.com29 May 2024 Sentiment: POSITIVE

CZ's Nested Vials are designed to meet the exterior dimensions of glass standard ISO 8362-1 and offer broad compatibility with various aseptic fill-finish equipment available in the market. EXTON, Pa.

West to Participate in Upcoming Investor Conference
prnewswire.com28 May 2024 Sentiment: POSITIVE

EXTON, Pa. , May 28, 2024 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will present at the William Blair 44th Annual Growth Stock Conference in Chicago, IL on Tuesday, June 4, 2024 at 8:00 AM CT. A live audio webcast of the event will be available in the "Investors" section of the Company's website at www.westpharma.com.

West Pharmaceutical Services, Inc. (WST) Q1 2024 Earnings Call Transcript
Seeking Alpha25 April 2024 Sentiment: POSITIVE

West Pharmaceutical Services, Inc. (NYSE: WST) will be holding its Q1 2024 Earnings Conference Call on April 25, 2024 at 9:00 AM ET. The call will feature Quintin Lai, Eric Green, and Bernard Birkett from the company. Various analysts and investors will also be participating in the call. Thank you for joining us for the West Pharmaceutical Services First Quarter 2024 Earnings Conference Call.

West Pharmaceutical (WST) Q1 Earnings Beat, HVP Sales Weak
Zacks Investment Research25 April 2024 Sentiment: POSITIVE

West Pharmaceutical's (WST) first-quarter performance is driven by robust demand for non-COVID-19 products, particularly HVP devices.

West Pharmaceutical Services (WST) Tops Q1 Earnings and Revenue Estimates
Zacks Investment Research25 April 2024 Sentiment: POSITIVE

West Pharmaceutical Services (WST) reported quarterly earnings of $1.56 per share, surpassing the Zacks Consensus Estimate of $1.29 per share. This is lower than the earnings of $1.98 per share reported a year ago.

West Pharma posts beat-and-raise quarter aided by strong demand for injectables
Reuters25 April 2024 Sentiment: POSITIVE

West Pharmaceutical Services exceeded quarterly profit expectations and increased its annual profit forecast, citing an increase in demand for cartridges and syringes used in the production of injectable treatments.

Reasons to Hold West Pharmaceutical (WST) in Your Portfolio Now
Zacks Investment Research17 April 2024 Sentiment: POSITIVE

West Pharmaceutical is still seeing strong growth in its Proprietary Products division, but worries about foreign exchange rates remain.

Reasons to Hold West Pharmaceutical (WST) in Your Portfolio Now
Zacks Investment Research14 March 2024 Sentiment: POSITIVE

West Pharmaceutical (WST) continues to gain momentum due to its strength in the Proprietary Products business. However, forex concerns persist.

Strength Seen in West Pharmaceutical (WST): Can Its 5.7% Jump Turn into More Strength?
Zacks Investment Research13 March 2024 Sentiment: POSITIVE

West Pharmaceutical (WST) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

  • 1(current)
  • 2
  • 3

What type of business is West Pharmaceutical Services?

West Pharmaceutical Services, Inc. produces and sells injection pharmaceutical packaging and delivery systems for medicines and medical devices. The company was founded in 1923 and is headquartered in Exton, Pennsylvania. The company operates in two segments: The proprietary products segment offers patented packaging, sealing, and delivery of medicines, as well as analytical laboratory services and comprehensive solutions, primarily for customers of biological, generic, and pharmaceutical products. The contract manufacturing segment is involved in the design, production, and automated assembly of components and devices used in surgical, diagnostic, ophthalmic, injection, and other drug delivery systems, as well as consumer goods. This segment serves pharmaceutical, diagnostic, and medical companies.

What sector is West Pharmaceutical Services in?

West Pharmaceutical Services is in the Healthcare sector

What industry is West Pharmaceutical Services in?

West Pharmaceutical Services is in the Medical Instruments & Supplies industry

What country is West Pharmaceutical Services from?

West Pharmaceutical Services is headquartered in United States

When did West Pharmaceutical Services go public?

West Pharmaceutical Services initial public offering (IPO) was on 17 March 1980

What is West Pharmaceutical Services website?

https://www.westpharma.com

Is West Pharmaceutical Services in the S&P 500?

Yes, West Pharmaceutical Services is included in the S&P 500 index

Is West Pharmaceutical Services in the NASDAQ 100?

No, West Pharmaceutical Services is not included in the NASDAQ 100 index

Is West Pharmaceutical Services in the Dow Jones?

No, West Pharmaceutical Services is not included in the Dow Jones index

When does West Pharmaceutical Services report earnings?

The next expected earnings date for West Pharmaceutical Services is 26 July 2024